GERD in the pediatric patient: Management considerations

MedGenMed Medscape General Medicine

Volumn 6, Issue 2, 2004, Pages

  Gremse, David A ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; CIMETIDINE; CISAPRIDE; ERYTHROMYCIN; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; METOCLOPRAMIDE; NIZATIDINE; OMEPRAZOLE; PLACEBO; PROKINETIC AGENT; PROTON PUMP INHIBITOR; RANITIDINE;

ABDOMINAL PAIN; ARTICLE; CLINICAL TRIAL; CONSTIPATION; DIARRHEA; DIETARY INTAKE; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG MEGADOSE; ESOPHAGITIS; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; GASTROESOPHAGEAL REFLUX; HEADACHE; HUMAN; LIFESTYLE; NEUROTOXICITY; OSTEOPENIA; STOMACH PARESIS; WEIGHT REDUCTION; ADOLESCENT; CHILD; INFANT; PRESCHOOL CHILD; REVIEW;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; GASTROESOPHAGEAL REFLUX; HUMANS; INFANT;

EID: 16444378264     PISSN: None     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Nelson SP, Chen EH, Syniar GM, Christoffel KK. Prevalence of symptoms of gastroesophageal reflux during infancy: a pediatric practice-based survey. Pediatric Practice Research Group. Arch Pediatr Adolesc Med. 1997;151:569-572.
2. Nelson SP, Chen EH, Syniar GM, Christoffel KK. Pediatric Practice Research Group. Prevalence of symptoms of gastroesophageal reflux during childhood. Arch Pediatr Adolesc Med. 2000;154:150-154.
3. Treem WR, Davis PM, Hyams JS. Gastroesophageal reflux in the older child: Presentation, response to treatment and long-term follow-up. Clin Pediatr. 1991;30:435-440.
4. Locke GR, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 1997;112:1448-1456.
5. Waring JP, Feiler MJ, Hunter JG, Smith CD, Gold BD. Childhood gastroesophageal reflux symptoms in adult patients. J Pediatr Gastroenterol Nutr. 2002;35:334-338.
6. Rudolph CD, Mazur LJ, Liptak GS, et al. Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children: recommendations of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr. 2001;32 (suppl):S1-31.
7. Heine RG, Cameron DJS, Chow CW, Hill DJ, Catto-Smith AG. Esophagitis in distressed infants: poor diagnostic agreement between esophageal pH monitoring and histopathologic findings. J Pediatr. 2002;140:14-19.
8. Colletti RD, Christie DL, Orenstein SR. Statement of the North American Society for Pediatric Gastroenterology and Nutrition (NASPGN). Indications for pediatric esophageal pH monitoring. J Pediatr Gastroenterol Nutr. 1995;21:253-262.
9. Gilger MA, Dietrich C, Gold B, et al. Does the endoscopic impression accurately predict histology in pediatric EGD. Gastroenterology. 2002;122:42.
10. Gupta SK, Fitzgerald JF, Chong SK, Croffie JM, Collins MH. Vertical lines in the distal esophageal mucosa (VLEM): a true endoscopic manifestation of esophagitis in children? Gastrointest Endosc. 1997;45:485-489.
11. Orenstein SR, Shalaby TM, Di Lorenzo C, et al. The spectrum of pediatric eosinophilic esophagitis beyond infancy: a clinical series of 30 children. Am J Gastroenterol. 2000;95:1422-430.
12. Orenstein SR, Magill HL, Brooks P. Thickening of infant feedings for therapy of gastroesophageal reflux. J Pediatr. 1987;110;181-186.
13. Vanderhoof JA, Moran JR, Harris CL, Merkel KL, Orenstein SR. Efficacy of a pre-thickened infant formula: a multicenter, double-blind, randomized, placebo-controlled parallel group trial in 104 infants with symptomatic gastroesophageal reflux. Clin Pediatr. 2003;42:483-495.
14. Shalaby TM, Orenstein SR. Efficacy of telephone teaching of conservative therapy for infants with symptomatic gastroesophageal reflux referred by pediatricians to pediatric gastroenterologists. J Pediatr. 2003;142:57-61.
15. Shabib SM, Cutz E, Sherman PM. Passive smoking is a risk factor for esophagitis in children. J Pediatr. 1995;127:435-437.
16. Gremse DA. Lansoprazole: pharmacokinetics, pharmacodynamics, and clinical uses. Exp Opin Pharmacother 2001;2:1663-1670.
17. Cucchiara S, Gobio-Casali L, Balli F, et al. Cimetidine treatment of reflux esophagitis in children: an Italian multicentric study. J Pediatr Gastroenterol Nutr. 1989;8:150-156.
18. Simeone D, Caria MC, Miele E, Staiano A. Treatment of childhood peptic esophagitis: a double-blind placebo-controlled trial of nizatidine. J Pediatr Gastroenterol Nutr. 1997;25:51-55.
19. O'Connor JB, Provenzale D, Brazer S. Economic considerations in the treatment of gastroesophageal reflux disease: a review. Am J Gastroenterol. 2000;95:3356-3364.
20. Cucchiara S, Staiano A, Romaniello G, et al. Antacids and cimetidine treatment for gastro-oesophageal reflux and peptic oesophagitis. Arch Dis Child. 1984;59:842-847.
21. Tsou VM, Young RM, Hart MH, Vanderhoof JA. Elevated plasma aluminum levels in normal infants receiving antacids containing aluminum. Pediatrics. 1991;87:148-151.
22. Curry JI, Lander TD, Stringer MD. Review article: erythromycin as a prokinetic agent in infants and children. Aliment Pharamacol Therap. 2001;15:595-603.
23. Cucchiara S, Franco MT, Terrin G, et al. Role of drug therapy in the treatment of gastro-oesophageal reflux disorder in children. Paediatr Drugs. 2000;2:263-272.
24. Chiba N, De Gara CJ, Wilkinson JM, et al. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta analysis. Gastroenterology. 1997;112:1798-1810.
25. Hassall E, Israel D, Shepherd R, et al. Omeprazole for treatment of chronic erosive esophagitis in children: a multicenter study of efficacy, safety, tolerability and dose requirements. J Pediatr. 2000;137:800-807.
26. Karjoo M, Kane R. Omeprazole treatment of children with peptic esophagitis refractory to ranitidine therapy. Arch Pediatr Adolesc Med. 1995;149:267-271.
27. Tolia V, Ferry G, Gunasekaran T, Huang B, Keith R, Book L. Efficacy of lansoprazole in the treatment of gastroesophageal reflux disease in children. J Pediatr Gastroenterol Nutr. 2002;35:S308-S318.
28. Faure C, Michaud L, Shaghaghi EK, et al. Lansoprazole in children: pharmacokinetics and efficacy in reflux oesophagitis. Aliment Pharmacol Ther. 2001;15:1397-1402.
29. Gremse D, Winter H, Tolia V, et al. Pharmacokinetics and pharmacodynamics of lansoprazole in children with gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr. 2002;35:S319-S326.
30. Gunasekaran T, Gupta S, Gremse D, et al. Lansoprazole in adolescents with gastroesophageal reflux disease: pharmacokinetics, pharmacodynamics, symptom relief efficacy, and tolerability. J Pediatr Gastroenterol Nutr. 2002;35:S327-S335.
31. Franco MT, Salvia G, Terrin G, et al. Lansoprazole in the treatment of gastro-oesophageal reflux disease in childhood. Dig Liver Dis. 2000;32:660-666.
32. Tolia V, Fitzgerald J, Hassall E, Huang B, Pilmer B, Kane R. Safety of lansoprazole in the treatment of gastroesophageal reflux disease in children. J Pediatr Gastroenterol Nutr. 2002;35:S300-S307.
33. Gremse DA, Donnelly JR, Kukulka MJ, Lloyd E, Lee C. A novel option for dosing of proton pump inhibitors: dispersion of lansoprazole orally disintegrating tablet (LODT) in water via oral syringe. Aliment Pharmacol Ther. 2004 (in press).
34. Di Lorenzo C, Orenstein S. Fundoplication: friend or foe? J Pediatr Gastroenterol Nutr. 2002;34:117-124.